Ablynx
Development of Nanobodies, proprietary therapeutic proteins.
Launch date
Employees
Market cap
-
Enterprise valuation
€3.9b (Public information from Jan 2018)
Company register number 0475.295.446
Ghent East Flanders (HQ)
Authorizing premium user...